SCHEMBL14906858

SCHEMBL14906858

COc1cc2cc(-c3cc(OC)c(OC)c(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c3)c3nccn3c2cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 4/20 0.43
▸ PTAFR P25105 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ PDGFRB P09619 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ TNK2 Q07912 2/20 0.36
▸ PAX8 Q06710 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ GLA P06280 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ ACACA Q13085 1/20 0.34
▸ IKBKB O14920 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14903972 0.88 PTAFR (0.40) FYNPTAFRPAX8ALDH1A1KDM4E
SCHEMBL12070662 0.82 PTAFR (0.51) FYNPTAFRCTDSP1PDGFRBPDGFRA
SCHEMBL16994469 0.80 PTAFR (0.38) PTAFRPDGFRBPDGFRAALDH1A1MAPT
SCHEMBL14927045 0.76 PTAFR (0.49) FYNPTAFRCTDSP1PAX8ALDH1A1
SCHEMBL12074764 0.74 CCNE1 (0.43) —
SCHEMBL14926992 0.73 PTAFR (0.51) FYNPTAFRPAX8ALDH1A1KDM4E
SCHEMBL12075016 0.72 PDGFRB (0.73) FYNPDGFRBPDGFRAALDH1A1MAPT
SCHEMBL12074258 0.68 PDGFRB (0.73) FYNPDGFRBPDGFRA
SCHEMBL12072009 0.68 CTDSP1 (0.46) FYNCTDSP1PDGFRBALDH1A1KDM4E
SCHEMBL14906991 0.67 PDGFRB (0.40) FYNCTDSP1PDGFRBPDGFRAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102617-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2015-08-11 — — US disclosed
US-20130109713-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY 2013-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109713-A1 ANTIMICROBIAL AGENTS RPS4X, RPS4Y1, MRPL21 FYN 4551/4885PTAFR 4433/4885CTDSP1 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback